Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05238103 · ClinicalTrials.gov registry record · NA

Impact of a Corrie Cardiac Rehabilitation Program

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
259
Enrollment target

NCT05238103: Completed NA study, sponsored by Johns Hopkins University.

NCT05238103 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 259 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05238103, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
259 participants
Enrollment target

Study Summary

In this randomized clinical trial, the researchers are investigating whether a multi-component virtual/hybrid cardiac rehabilitation program will improve functional status, cholesterol level, overall cardiovascular health, individual risk factors, quality of life and mental health for patients who have recently been diagnosed with myocardial infarction, received a coronary stent, underwent heart surgery or catheter-based valve replacement, as compared to traditional, center-based cardiac rehabilitation.

Interventions

  • COMBINATION_PRODUCT Corrie Hybrid Cardiac Rehabilitation Program

Trial Details

FieldValue
Enrollment Target 259 participants
Start Date 2023-04-03
Est. Completion 2024-10-14
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05238103

The ClinicalTrials.gov registry entry for NCT05238103 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 259 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Corrie Hybrid Cardiac Rehabilitation Program is the first listed.

NCT05238103 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05238103 about?

NCT05238103 is a clinical study titled "Impact of a Corrie Cardiac Rehabilitation Program". In this randomized clinical trial, the researchers are investigating whether a multi-component virtual/hybrid cardiac rehabilitation program will improve functional status, cholesterol level, overall cardiovascular health, individual risk factors, quality of life and mental health for patients who h...

What is the current status of trial NCT05238103?

This trial is currently completed. It is a NA study. The enrollment target is 259 participants. The study started on 2023-04-03. Estimated completion is 2024-10-14.

What interventions are being tested in trial NCT05238103?

The interventions under investigation include: Corrie Hybrid Cardiac Rehabilitation Program (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT05238103?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.